{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:43:31Z","timestamp":1781664211851,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["WI236621"],"award-info":[{"award-number":["WI236621"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Community-acquired pneumonia is an important cause of morbidity and mortality in adults. Approximately one-third of pneumonia cases can be attributed to the pneumococcus. Pneumococcal conjugate vaccines (PCVs) protect against colonisation with vaccine-type serotypes. The resulting decrease in transmission of vaccine serotypes leads to large indirect effects. There are limited data from developing countries demonstrating the impact of childhood PCV immunisation on adult pneumonia. There are also insufficient data available on the burden and severity of all-cause pneumonia and respiratory syncytial virus (RSV) in adults from low resource countries. There is currently no recommendation for adult pneumococcal vaccination with either pneumococcal polysaccharide vaccine or PCVs in Mongolia. We describe the protocol developed to evaluate the association between childhood 13-valent PCV (PCV13) vaccination and trends in adult pneumonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PCV13 was introduced into the routine childhood immunisation schedule in Mongolia in a phased manner from 2016. In March 2019 we initiated active hospital-based surveillance for adult pneumonia, with the primary objective of evaluating trends in severe hospitalised clinical pneumonia incidence in adults 18\u2009years and older in four districts of Ulaanbaatar. Secondary objectives include measuring the association between PCV13 introduction and trends in all clinically-defined pneumonia, radiologically-confirmed pneumonia, nasopharyngeal carriage of <jats:italic>S. pneumoniae<\/jats:italic> and pneumonia associated with RSV or influenza. Clinical questionnaires, nasopharyngeal swabs, urine samples and chest radiographs were collected from enrolled patients. Retrospective administrative and clinical data were collected for all respiratory disease-related admissions from January 2015 to February 2019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Establishing a robust adult surveillance system may be an important component of monitoring the indirect impact of PCVs within a country. Monitoring indirect impact of childhood PCV13 vaccination on adult pneumonia provides additional data on the full public health impact of the vaccine, which has implications for vaccine efficiency and cost-effectiveness. Adult surveillance in Mongolia will contribute to the limited evidence available on the burden of pneumococcal pneumonia among adults in low- and middle-income countries, particularly in the Asia-Pacific region. In addition, it is one of the few examples of implementing prospective, population-based pneumonia surveillance to evaluate the indirect impact of PCVs in a resource-limited setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11776-8","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T21:04:21Z","timestamp":1632431061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-1731","authenticated-orcid":false,"given":"Claire","family":"von Mollendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukhchuluun","family":"Ulziibayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien Anh Ha","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cattram D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Beavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bujinlkham","family":"Suuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashtseren","family":"Luvsantseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorj","family":"Narangerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Jenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Satzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badarchiin","family":"Darmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuya","family":"Mungun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kim","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"4","key":"11776_CR1","doi-asserted-by":"publisher","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","volume":"8","author":"MA Said","year":"2013","unstructured":"Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL, Team AAPBS, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013;8(4):e60273. https:\/\/doi.org\/10.1371\/journal.pone.0060273.","journal-title":"PLoS One"},{"issue":"4","key":"11776_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3947\/ic.2013.45.4.351","volume":"45","author":"JY Song","year":"2013","unstructured":"Song JY, Eun BW, Nahm MH. Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward. Infect Chemother. 2013;45(4):351\u201366. https:\/\/doi.org\/10.3947\/ic.2013.45.4.351.","journal-title":"Infect Chemother"},{"issue":"9","key":"11776_CR3","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1093\/cid\/ciaa158","volume":"71","author":"WV Kalina","year":"2020","unstructured":"Kalina WV, Souza V, Wu K, Giardina P, McKeen A, Jiang Q, et al. Qualification and clinical validation of an immunodiagnostic assay for detecting 11 additional Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Infect Dis. 2020;71(9):e430\u20138. https:\/\/doi.org\/10.1093\/cid\/ciaa158.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"11776_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1128\/CVI.00064-12","volume":"19","author":"MW Pride","year":"2012","unstructured":"Pride MW, Huijts SM, Wu K, Souza V, Passador S, Tinder C, et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vaccine Immunol. 2012;19(8):1131\u201341. https:\/\/doi.org\/10.1128\/CVI.00064-12.","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"11776_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1586\/erv.12.53","volume":"11","author":"B Simell","year":"2012","unstructured":"Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, O'Brien KL, et al. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11(7):841\u201355. https:\/\/doi.org\/10.1586\/erv.12.53.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"11776_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","volume":"32","author":"SM Davis","year":"2013","unstructured":"Davis SM, Deloria-Knoll M, Kassa HT, O'Brien KL. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine. 2013;32(1):133\u201345. https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.005.","journal-title":"Vaccine"},{"issue":"22","key":"11776_CR7","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.vaccine.2017.04.032","volume":"35","author":"G Tsaban","year":"2017","unstructured":"Tsaban G, Ben-Shimol S. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: a systematic review of the literature. Vaccine. 2017;35(22):2882\u201391. https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.032.","journal-title":"Vaccine"},{"issue":"4","key":"11776_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3947\/ic.2016.48.4.257","volume":"48","author":"YK Kim","year":"2016","unstructured":"Kim YK, LaFon D, Nahm MH. Indirect effects of Pneumococcal conjugate vaccines in National Immunization Programs for children on adult Pneumococcal disease. Infect Chemother. 2016;48(4):257\u201366. https:\/\/doi.org\/10.3947\/ic.2016.48.4.257.","journal-title":"Infect Chemother"},{"issue":"1","key":"11776_CR9","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","volume":"5","author":"T Shiri","year":"2017","unstructured":"Shiri T, Datta S, Madan J, Tsertsvadze A, Royle P, Keeling MJ, et al. Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(1):e51\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(16)30306-0.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"11776_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1473-3099(15)70007-1","volume":"15","author":"M Hamaluba","year":"2015","unstructured":"Hamaluba M, Kandasamy R, Upreti SR, Subedi GR, Shrestha S, Bhattarai S, et al. Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial. Lancet Infect Dis. 2015;15(4):405\u201314. https:\/\/doi.org\/10.1016\/S1473-3099(15)70007-1.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"11776_CR11","doi-asserted-by":"publisher","first-page":"e0231041","DOI":"10.1371\/journal.pone.0231041","volume":"15","author":"EFG Neal","year":"2020","unstructured":"Neal EFG, Nguyen CD, Ratu FT, Dunne EM, Kama M, Ortika BD, et al. Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys. PLoS One. 2020;15(4):e0231041. https:\/\/doi.org\/10.1371\/journal.pone.0231041.","journal-title":"PLoS One"},{"issue":"10","key":"11776_CR12","doi-asserted-by":"publisher","first-page":"e0224392","DOI":"10.1371\/journal.pone.0224392","volume":"14","author":"EM Dunne","year":"2019","unstructured":"Dunne EM, Choummanivong M, Neal EFG, Stanhope K, Nguyen CD, Xeuatvongsa A, et al. Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR. PLoS One. 2019;14(10):e0224392. https:\/\/doi.org\/10.1371\/journal.pone.0224392.","journal-title":"PLoS One"},{"issue":"3","key":"11776_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/1759-7714.13323","volume":"11","author":"Y Cao","year":"2020","unstructured":"Cao Y, Chen M, Dong D, Xie S, Liu M. Environmental pollutants damage airway epithelial cell cilia: implications for the prevention of obstructive lung diseases. Thorac Cancer. 2020;11(3):505\u201310. https:\/\/doi.org\/10.1111\/1759-7714.13323.","journal-title":"Thorac Cancer"},{"issue":"1","key":"11776_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2334-10-22","volume":"10","author":"BD Gessner","year":"2010","unstructured":"Gessner BD, Mueller JE, Yaro S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect Dis. 2010;10(1):22. https:\/\/doi.org\/10.1186\/1471-2334-10-22.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"11776_CR15","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/cid\/ciz139","volume":"69","author":"GM Bigogo","year":"2019","unstructured":"Bigogo GM, Audi A, Auko J, Aol GO, Ochieng BJ, Odiembo H, et al. Indirect effects of 10-Valent Pneumococcal conjugate Vaccine against adult Pneumococcal pneumonia in rural Western Kenya. Clin Infect Dis. 2019;69(12):2177\u201384. https:\/\/doi.org\/10.1093\/cid\/ciz139.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"11776_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nm1077","volume":"10","author":"SA Madhi","year":"2004","unstructured":"Madhi SA, Klugman KP, Vaccine Trialist G. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10(8):811\u20133. https:\/\/doi.org\/10.1038\/nm1077.","journal-title":"Nat Med"},{"issue":"3","key":"11776_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/CMR.00058-05","volume":"19","author":"JA McCullers","year":"2006","unstructured":"McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19(3):571\u201382. https:\/\/doi.org\/10.1128\/CMR.00058-05.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"11776_CR18","doi-asserted-by":"publisher","first-page":"e1001776","DOI":"10.1371\/journal.pmed.1001776","volume":"12","author":"DM Weinberger","year":"2015","unstructured":"Weinberger DM, Klugman KP, Steiner CA, Simonsen L, Viboud C. Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data. PLoS Med. 2015;12(1):e1001776. https:\/\/doi.org\/10.1371\/journal.pmed.1001776.","journal-title":"PLoS Med"},{"issue":"7","key":"11776_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/cid\/cix923","volume":"66","author":"P Fathima","year":"2018","unstructured":"Fathima P, Blyth CC, Lehmann D, Lim FJ, Abdalla T, de Klerk N, et al. The impact of Pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469589 births, 1996-2012. Clin Infect Dis. 2018;66(7):1075\u201385. https:\/\/doi.org\/10.1093\/cid\/cix923.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11776_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/thx.2006.075077","volume":"63","author":"LC Jennings","year":"2008","unstructured":"Jennings LC, Anderson TP, Beynon KA, Chua A, Laing RT, Werno AM, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63(1):42\u20138. https:\/\/doi.org\/10.1136\/thx.2006.075077.","journal-title":"Thorax"},{"issue":"6","key":"11776_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1378\/chest.08-0888","volume":"134","author":"J Johnstone","year":"2008","unstructured":"Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest. 2008;134(6):1141\u20138. https:\/\/doi.org\/10.1378\/chest.08-0888.","journal-title":"Chest"},{"issue":"1","key":"11776_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10096-018-3407-3","volume":"38","author":"M Jeannoel","year":"2019","unstructured":"Jeannoel M, Lina G, Rasigade JP, Lina B, Morfin F, Casalegno JS. Microorganisms associated with respiratory syncytial virus pneumonia in the adult population. Eur J Clin Microbiol Infect Dis. 2019;38(1):157\u201360. https:\/\/doi.org\/10.1007\/s10096-018-3407-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"11776_CR23","volume-title":"Health Indicators 2018","author":"Centre for Health Development","year":"2018","unstructured":"Centre for Health Development. Health Indicators 2018. Ulaanbaatar: Centre for Health Development; 2018."},{"issue":"5","key":"11776_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/irv.12268","volume":"8","author":"A Burmaa","year":"2014","unstructured":"Burmaa A, Kamigaki T, Darmaa B, Nymadawa P, Oshitani H. Epidemiology and impact of influenza in Mongolia, 2007-2012. Influenza Other Respir Viruses. 2014;8(5):530\u20137. https:\/\/doi.org\/10.1111\/irv.12268.","journal-title":"Influenza Other Respir Viruses"},{"key":"11776_CR25","volume-title":"Air Quality Analysis of Ulaanbaatar. Improving Air Quality to Reduce Health Impacts","author":"World Bank","year":"2011","unstructured":"World Bank. Sustainable Development Department (EASSD) of the East Asia and Pacific Region. In: Air Quality Analysis of Ulaanbaatar. Improving Air Quality to Reduce Health Impacts. December 2011; 2011."},{"issue":"2","key":"11776_CR26","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.020431","volume":"9","author":"KNA Pangesti","year":"2019","unstructured":"Pangesti KNA, El Ghany MA, Kesson AM, Hill-Cawthorne GA. Respiratory syncytial virus in the Western Pacific region: a systematic review and meta-analysis. J Glob Health. 2019;9(2):020431. https:\/\/doi.org\/10.7189\/jogh.09.020431.","journal-title":"J Glob Health"},{"issue":"1","key":"11776_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12889-019-6639-y","volume":"19","author":"SF La Vincente","year":"2019","unstructured":"La Vincente SF, von Mollendorf C, Ulziibayar M, Satzke C, Dashtseren L, Fox KK, et al. Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned. BMC Public Health. 2019;19(1):333. https:\/\/doi.org\/10.1186\/s12889-019-6639-y.","journal-title":"BMC Public Health"},{"issue":"9","key":"11776_CR28","doi-asserted-by":"publisher","first-page":"e0222423","DOI":"10.1371\/journal.pone.0222423","volume":"14","author":"C von Mollendorf","year":"2019","unstructured":"von Mollendorf C, La Vincente S, Ulziibayar M, Suuri B, Luvsantseren D, Narangerel D, et al. Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016. PLoS One. 2019;14(9):e0222423. https:\/\/doi.org\/10.1371\/journal.pone.0222423.","journal-title":"PLoS One"},{"issue":"30","key":"11776_CR29","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1016\/j.vaccine.2019.05.078","volume":"37","author":"C von Mollendorf","year":"2019","unstructured":"von Mollendorf C, Dunne EM, La Vincente S, Ulziibayar M, Suuri B, Luvsantseren D, et al. Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019;37(30):4068\u201375. https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.078.","journal-title":"Vaccine"},{"key":"11776_CR30","volume-title":"Primary health care systems (PRIMASYS): comprehensive case study from Mongolia","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Primary health care systems (PRIMASYS): comprehensive case study from Mongolia. Geneva: WHO; 2017."},{"key":"11776_CR31","unstructured":"Tsilaajav T, Ser-Od E, Baasai B, Byambaa G, Shagdarsuren O. Mongolia Health System Review, vol. 3. Manila: World Health Organization, Regional Office for the Western Pacific; 2013."},{"issue":"5","key":"11776_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1500245.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"11776_CR33","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27\u201372. https:\/\/doi.org\/10.1086\/511159.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"11776_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"5","key":"11776_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377\u201382. https:\/\/doi.org\/10.1136\/thorax.58.5.377.","journal-title":"Thorax"},{"issue":"5","key":"11776_CR36","first-page":"353","volume":"83","author":"T Cherian","year":"2005","unstructured":"Cherian T, Mulholland EK, Carlin JB, Ostensen H, Amin R, de Campo M, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83(5):353\u20139.","journal-title":"Bull World Health Organ"},{"issue":"8","key":"11776_CR37","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1128\/JCM.02498-06","volume":"45","author":"G Carvalho Mda","year":"2007","unstructured":"Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45(8):2460\u20136. https:\/\/doi.org\/10.1128\/JCM.02498-06.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"11776_CR38","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/infdis\/jix449","volume":"216","author":"JE Hagan","year":"2017","unstructured":"Hagan JE, Takashima Y, Sarankhuu A, Dashpagma O, Jantsansengee B, Pastore R, et al. Risk factors for measles virus infection among adults during a large outbreak in Postelimination era in Mongolia, 2015. J Infect Dis. 2017;216(10):1187\u201395. https:\/\/doi.org\/10.1093\/infdis\/jix449.","journal-title":"J Infect Dis"},{"issue":"11","key":"11776_CR39","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/infdis\/jiz140","volume":"220","author":"CT Lee","year":"2019","unstructured":"Lee CT, Hagan JE, Jantsansengee B, Tumurbaatar OE, Altanchimeg S, Yadamsuren B, et al. Increase in infant measles deaths during a Nationwide measles outbreak-Mongolia, 2015-2016. J Infect Dis. 2019;220(11):1771\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiz140.","journal-title":"J Infect Dis"},{"issue":"2","key":"11776_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10096-008-0606-3","volume":"28","author":"F Andreo","year":"2009","unstructured":"Andreo F, Prat C, Ruiz-Manzano J, Lores L, Blanco S, Cuesta MA, et al. Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis. 2009;28(2):197\u2013201. https:\/\/doi.org\/10.1007\/s10096-008-0606-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"11776_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","volume":"32","author":"C Satzke","year":"2013","unstructured":"Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage working group. Vaccine. 2013;32(1):165\u201379. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.062.","journal-title":"Vaccine"},{"issue":"11","key":"11776_CR42","doi-asserted-by":"publisher","first-page":"e1001903","DOI":"10.1371\/journal.pmed.1001903","volume":"12","author":"C Satzke","year":"2015","unstructured":"Satzke C, Dunne EM, Porter BD, Klugman KP, Mulholland EK, PneuCarriage Project Group. The PneuCarriage project: a multi-Centre comparative study to identify the best serotyping methods for examining Pneumococcal Carriage in Vaccine evaluation studies. PLoS Med. 2015;12(11):e1001903. https:\/\/doi.org\/10.1371\/journal.pmed.1001903.","journal-title":"PLoS Med"},{"issue":"1","key":"11776_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jviromet.2011.11.012","volume":"179","author":"LA Do","year":"2012","unstructured":"Do LA, van Doorn HR, Bryant JE, Nghiem MN, Nguyen Van VC, Vo CK, et al. A sensitive real-time PCR for detection and subgrouping of human respiratory syncytial virus. J Virol Methods. 2012;179(1):250\u20135. https:\/\/doi.org\/10.1016\/j.jviromet.2011.11.012.","journal-title":"J Virol Methods"},{"issue":"2","key":"11776_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cct.2006.05.007","volume":"28","author":"MA Hussey","year":"2007","unstructured":"Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182\u201391. https:\/\/doi.org\/10.1016\/j.cct.2006.05.007.","journal-title":"Contemp Clin Trials"},{"key":"11776_CR45","first-page":"363","volume-title":"Stata Journal Volume 2","author":"K Hemming","year":"2014","unstructured":"Hemming K, Girling AJ. A menu-driven facility for power and detectable-difference calculations in stepped-wedge cluster-randomized trials. In: Newton HJ, Cox NJ, editors. Stata Journal Volume 2; 2014. p. 363\u201380."},{"issue":"6","key":"11776_CR46","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/EDE.0000000000001088","volume":"30","author":"JP Vandenbroucke","year":"2019","unstructured":"Vandenbroucke JP, Pearce N. Test-negative designs: differences and commonalities with other case-control studies with \u201cother patient\u201d controls. Epidemiology. 2019;30(6):838\u201344. https:\/\/doi.org\/10.1097\/EDE.0000000000001088.","journal-title":"Epidemiology"},{"issue":"2","key":"11776_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.clinthera.2008.02.003","volume":"30","author":"DJ Isaacman","year":"2008","unstructured":"Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, et al. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine. Clin Ther. 2008;30(2):341\u201357. https:\/\/doi.org\/10.1016\/j.clinthera.2008.02.003.","journal-title":"Clin Ther"},{"issue":"6","key":"11776_CR48","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/01.inf.0000222403.42974.8b","volume":"25","author":"GT Ray","year":"2006","unstructured":"Ray GT, Whitney CG, Fireman BH, Ciuryla V, Black SB. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J. 2006;25(6):494\u2013501. https:\/\/doi.org\/10.1097\/01.inf.0000222403.42974.8b.","journal-title":"Pediatr Infect Dis J"},{"key":"11776_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eclinm.2018.12.007","volume":"6","author":"A Djennad","year":"2018","unstructured":"Djennad A, Ramsay ME, Pebody R, Fry NK, Sheppard C, Ladhani SN, et al. Effectiveness of 23-Valent polysaccharide Pneumococcal Vaccine and changes in invasive Pneumococcal disease incidence from 2000 to 2017 in those aged 65 and over in England and Wales. EClinicalMedicine. 2018;6:42\u201350. https:\/\/doi.org\/10.1016\/j.eclinm.2018.12.007.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"11776_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","volume":"75","author":"H Pick","year":"2020","unstructured":"Pick H, Daniel P, Rodrigo C, Bewick T, Ashton D, Lawrence H, et al. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18. Thorax. 2020;75(1):38\u201349. https:\/\/doi.org\/10.1136\/thoraxjnl-2019-213725.","journal-title":"Thorax"},{"issue":"25","key":"11776_CR51","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","volume":"37","author":"RE Isturiz","year":"2019","unstructured":"Isturiz RE, Ramirez J, Self WH, Grijalva CG, Counselman FL, Volturo G, et al. Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia. Vaccine. 2019;37(25):3352\u201361. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.087.","journal-title":"Vaccine"},{"issue":"12","key":"11776_CR52","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/cid\/ciy993","volume":"68","author":"M Kolditz","year":"2019","unstructured":"Kolditz M, Schmitt J, Pletz MW, Tesch F. Impact of the 13-Valent Pneumococcal conjugate Vaccine on the incidence of all-cause pneumonia in adults aged >\/=60 years: a population-based, Retrospective Cohort Study. Clin Infect Dis. 2019;68(12):2117\u20139. https:\/\/doi.org\/10.1093\/cid\/ciy993.","journal-title":"Clin Infect Dis"},{"key":"11776_CR53","doi-asserted-by":"publisher","unstructured":"Lewnard JA, Bruxvoort KJ, Fischer H, Hong VX, Grant LR, J\u00f3dar L, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults. medRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.06.30.21259721.","DOI":"10.1101\/2021.06.30.21259721"},{"issue":"52","key":"11776_CR54","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","volume":"31","author":"A Steens","year":"2013","unstructured":"Steens A, Bergsaker MA, Aaberge IS, Ronning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013;31(52):6232\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.032.","journal-title":"Vaccine"},{"issue":"1","key":"11776_CR55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1471-2334-10-304","volume":"10","author":"GA Mackenzie","year":"2010","unstructured":"Mackenzie GA, Leach AJ, Carapetis JR, Fisher J, Morris PS. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis. 2010;10(1):304. https:\/\/doi.org\/10.1186\/1471-2334-10-304.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11776-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T21:09:37Z","timestamp":1632431377000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11776-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11776"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11776-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is being conducted according to protocols approved by the following ethics committees: Mongolian National Ethics Committee for Health Research and the Royal Children\u2019s Hospital Human Research Ethics Committee (38045B). Written consent will be obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual identifiers have been included in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BDG and RB are employees of Pfizer Inc. and provided input on the study protocol and manuscript. EMD is currently an employee of Pfizer Inc. (from August 2021), but worked for MCRI at the time that the microbiological field and laboratory protocols were developed. CvM, MU, LAHD, CDN, BS, DL, DN, AJ, CS, BD, TM and EKM are investigators on this collaborative research project funded by Pfizer.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1731"}}